I have been lurking here for some time and contributing (in my own small way) with share purchases. I am a doctor but in a field very far removed from ophthalmology! I agree with others here that the iTrack glaucoma therapy and market for it already justifies a valuation above the current "microcap" level. However the exciting prospect for me really is the alphaRET/2RT laser treatment for macular degeneration.
The LEAD trial already gives tantalising flashes into what might be possible in a very underserved pathology and very large market, looking at the FDA interactions it looks like they want a bigger, possibly longer duration trial for proof of efficacy? Can anyone tell me if that next trial is funded, enrolling, or otherwise defined and the likely timeframes/roadmap to generate enough data to satisfy the FDA?? Apologies if there's a company resource/presentation with details available but essentially where are we at with the 'pivotal trial' step and what hoops/costs/timeframes are involved to clear that hurdle and apply for full FDA approval??
Thanks for any insights.
- Forums
- ASX - By Stock
- EYE
- Nova Eye Medical (EYE) Discussion
Nova Eye Medical (EYE) Discussion, page-595
-
- There are more pages in this discussion • 2,593 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.3¢ |
Change
0.003(1.39%) |
Mkt cap ! $41.80M |
Open | High | Low | Value | Volume |
18.0¢ | 18.5¢ | 18.0¢ | $5.785K | 31.50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 124385 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 18889 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 124385 | 0.180 |
2 | 100000 | 0.175 |
5 | 153000 | 0.170 |
3 | 34241 | 0.165 |
8 | 434100 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 18889 | 1 |
0.190 | 50000 | 1 |
0.200 | 93423 | 2 |
0.205 | 15050 | 1 |
0.215 | 304291 | 5 |
Last trade - 15.09pm 30/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |